Skip to content

Influence of Stroke on the Composition of Intestinal Microbiota

Influence of Stroke on the Composition of Intestinal Microbiota (GUTSTROKE)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02008604
Acronym
GUTSTROKE
Enrollment
24
Registered
2013-12-11
Start date
2014-06-30
Completion date
2018-04-30
Last updated
2018-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Transient Ischemic Attack (TIA)

Keywords

ischemia, stroke, transient ischemic attack (TIA), microbiome, microbiota, gut

Brief summary

The aim of the study is to verify the hypothesis that the microbial colonisation of the gut is changed in patients after stroke and that the gut microbiome of severely affected stroke patients differs from that of patients with only a short disruption of blood circulation in the brain (transient ischemic attack, TIA). For this, the composition of gut microbiota in stool samples will be analyzed by 454 pyrosequencing. Further, the correlation of stroke-associated changes in the microbiome with immunological parameters will be analyzed.

Interventions

None listed

Sponsors

Prof. Dr. Ulrich Dirnagl, Experimental Neurology, Charité Berlin, Germany
CollaboratorUNKNOWN
Dr. Christian Meisel, Medical Immunology, Charité Berlin, Germany
CollaboratorUNKNOWN
PD Dr. Andreas Nitsche, Robert-Koch-Institut, Berlin, Germany
CollaboratorUNKNOWN
NeuroCure Clinical Research Center, Charite, Berlin
CollaboratorOTHER
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age: 18 and older * ischemic cerebral infarction within the last 40 hours, anterior circulation infarct (ACA, MCA) and/or posterior circulation infarct (PCA, BA) of any severity * patient consent or consent by a legal representative * NIHSS \> or =9 (stroke patients) * NIHSS \< 1 (for TIA patients)

Exclusion criteria

* intracranial hemorrhage * preexisting dysphagia * signs of infection upon admission (clinical/paraclinical) * existing antibiotic therapy upon admission or within the last 2 weeks before admission * mechanical ventilation upon admission * participation in an interventional therapy study

Design outcomes

Primary

MeasureTime frameDescription
composition of intestinal microbiomechange between day 1, day 4, day 7, day 14 after strokeThe composition of the intestinal metagenome / microbiome will be determined by analyzing the 16S rRNA by 454 Pyrosequencing.

Secondary

MeasureTime frameDescription
test of correlation between most changed group of bacteria with changes in immunological parameters (HLA-DR)days 1, 4, 7 after strokeAnalysis of correlation between changes in microbiome (most changed group of bacteria, e.g. lactobacilli) with changes in immunological parameters (e.g. HLA-DR, IL-6, IL-10, CD4-lymphocytes from blood samples).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026